210 related articles for article (PubMed ID: 2973542)
1. Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix.
Yahalom J; Fibach E; Bar-Tana R; Fuks Z; Vlodavsky I
Leuk Res; 1988; 12(9):711-7. PubMed ID: 2973542
[TBL] [Abstract][Full Text] [Related]
2. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix.
Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I
J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287
[TBL] [Abstract][Full Text] [Related]
3. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells.
Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I
Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649
[TBL] [Abstract][Full Text] [Related]
4. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix.
Bashkin P; Razin E; Eldor A; Vlodavsky I
Blood; 1990 Jun; 75(11):2204-12. PubMed ID: 1693299
[TBL] [Abstract][Full Text] [Related]
5. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
Benezra M; Vlodavsky I; Bar-Shavit R
Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
[TBL] [Abstract][Full Text] [Related]
6. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.
Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR
J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294
[TBL] [Abstract][Full Text] [Related]
7. Heparanase activity in cultured endothelial cells.
Godder K; Vlodavsky I; Eldor A; Weksler BB; Haimovitz-Freidman A; Fuks Z
J Cell Physiol; 1991 Aug; 148(2):274-80. PubMed ID: 1880155
[TBL] [Abstract][Full Text] [Related]
8. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
Marchetti D; Liu S; Spohn WC; Carson DD
J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
[TBL] [Abstract][Full Text] [Related]
9. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
Savion N; Disatnik MH; Nevo Z
J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
[TBL] [Abstract][Full Text] [Related]
10. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
[TBL] [Abstract][Full Text] [Related]
11. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.
Matzner Y; Bar-Ner M; Yahalom J; Ishai-Michaeli R; Fuks Z; Vlodavsky I
J Clin Invest; 1985 Oct; 76(4):1306-13. PubMed ID: 2997275
[TBL] [Abstract][Full Text] [Related]
12. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
[TBL] [Abstract][Full Text] [Related]
14. Subcellular localization of heparanase in human neutrophils.
Matzner Y; Vlodavsky I; Bar-Ner M; Ishai-Michaeli R; Tauber AI
J Leukoc Biol; 1992 Jun; 51(6):519-24. PubMed ID: 1613389
[TBL] [Abstract][Full Text] [Related]
15. Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens.
Peretz T; Antebi SU; Beller U; Horowitz AT; Fuks Z; Vlodavsky I
Int J Cancer; 1990 Jun; 45(6):1054-60. PubMed ID: 2190937
[TBL] [Abstract][Full Text] [Related]
16. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells.
Benhamron S; Nechushtan H; Verbovetski I; Krispin A; Abboud-Jarrous G; Zcharia E; Edovitsky E; Nahari E; Peretz T; Vlodavsky I; Mevorach D
J Immunol; 2006 Jun; 176(11):6417-24. PubMed ID: 16709798
[TBL] [Abstract][Full Text] [Related]
17. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; Nicolson GL
Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967
[TBL] [Abstract][Full Text] [Related]
18. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
20. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
